LeonaBio (LONA) Accounts Payables (2019 - 2026)
LeonaBio (LONA) posted quarterly Accounts Payables of $1.8 million for Q1 2026, up 103.46% year-over-year from $867000.0 in Q1 2025, and down 61.54% quarter-over-quarter from $4.6 million in Q4 2025.
LeonaBio (LONA) Accounts Payables (2019 - 2026) Analysis & Trends
LeonaBio (LONA) has reported Accounts Payables for 8 consecutive years, with $1.8 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Accounts Payables rose 103.46% year-over-year to $1.8 million; the TTM figure through Mar 2026 stood at $1.8 million (up 103.46% YoY), while the FY2025 annual figure was $4.6 million, up 1337.93% from the prior year.
- Accounts Payables slipped to $1.8 million in Q1 2026 per LONA's latest filing, from $4.6 million in the prior quarter.
- Across five years, Accounts Payables topped out at $4.6 million in Q4 2025 and bottomed at $129000.0 in Q4 2023.
- Historically, Accounts Payables has averaged $1.1 million across 5 years, with a median of $681000.0 in 2024.
- Annual changes were most pronounced in 2023 — Accounts Payables tumbled 94.84% — and 2025, when it surged 1337.93%.
- LeonaBio's Accounts Payables stood at $2.5 million in 2022, then sank by 94.84% to $129000.0 in 2023, then jumped by 147.29% to $319000.0 in 2024, then soared by 1337.93% to $4.6 million in 2025, then sank by 61.54% to $1.8 million in 2026.
- Business Quant data shows LONA's Accounts Payables at $1.8 million in Q1 2026, $4.6 million in Q4 2025, and $266000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Accounts Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 429.50 Mn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 1.16 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | 1.52 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | 167.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 470.30 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 108.02 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 622.65 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 428.93 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 35.57 Mn |
| 10 | LeonaBio | 180.91 Mn | 129.85 Mn | - | 2.42 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.76 Mn |
| Dec 31, 2025 | 4.59 Mn |
| Sep 30, 2025 | 266,000.00 |
| Jun 30, 2025 | 171,000.00 |
| Mar 31, 2025 | 867,000.00 |
| Dec 31, 2024 | 319,000.00 |
| Sep 30, 2024 | 388,000.00 |
| Jun 30, 2024 | 475,000.00 |
| Mar 31, 2024 | 681,000.00 |
| Dec 31, 2023 | 129,000.00 |
| Sep 30, 2023 | 1.71 Mn |
| Jun 30, 2023 | 612,000.00 |
| Mar 31, 2023 | 892,000.00 |
| Dec 31, 2022 | 2.50 Mn |
| Sep 30, 2022 | 751,000.00 |
| Jun 30, 2022 | 605,000.00 |
| Mar 31, 2022 | 1.43 Mn |
| Dec 31, 2021 | 567,000.00 |
| Sep 30, 2021 | 959,000.00 |
| Jun 30, 2021 | 1.17 Mn |